301130.SZ
Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 24.90
+2.68%Margins
Gross margin
75.4%
EBITDA margin
23.3%
EBIT margin
8.9%
Net margin
9.6%
FCF margin
-7.3%
2.6%
Return on equity
2.2%
Return on assets
2.3%
Return on invested capital
0.23x
Asset turnover
CNY 50.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026